These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Autoimmunity and idiopathic dilated cardiomyopathy: where we stand? Fu M Autoimmunity; 2008 Sep; 41(6):415-8. PubMed ID: 18781466 [TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy. Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy. Okazaki T; Honjo T Trends Mol Med; 2005 Jul; 11(7):322-6. PubMed ID: 15935731 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression and autoimmunity of recombination signal binding protein-jkappa in human dilated cardiomyopathy. Nickenig G; Wolff M; Stäblein A; Pfister H; Böhm M Biochem Biophys Res Commun; 1999 Dec; 266(2):432-6. PubMed ID: 10600520 [TBL] [Abstract][Full Text] [Related]
14. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841 [TBL] [Abstract][Full Text] [Related]
15. Are autoantibodies against the beta1-adrenergic receptor markers for dilated cardiomyopathy? Arndt-Marić R; Nägele H; Schewe G; Kromminga A Clin Lab; 2010; 56(11-12):519-26. PubMed ID: 21141435 [TBL] [Abstract][Full Text] [Related]
17. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Horn S; Lueking A; Murphy D; Staudt A; Gutjahr C; Schulte K; König A; Landsberger M; Lehrach H; Felix SB; Cahill DJ Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013 [TBL] [Abstract][Full Text] [Related]
18. [The pathogenesis of dilated cardiomyopathy: current progress]. Mestroni L; Giacca M; Severini GM; Camerini F G Ital Cardiol; 1992 Jan; 22(1):53-62. PubMed ID: 1624069 [TBL] [Abstract][Full Text] [Related]
19. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study. Deubner N; Berliner D; Schlipp A; Gelbrich G; Caforio AL; Felix SB; Fu M; Katus H; Angermann CE; Lohse MJ; Ertl G; Störk S; Jahns R; Eur J Heart Fail; 2010 Jul; 12(7):753-62. PubMed ID: 20494925 [TBL] [Abstract][Full Text] [Related]
20. [Dilated cardiomyopathy--heart muscle disease of unknown origin or an autoimmune disease? New aspects of etiology, pathogenesis and clinical practice]. Müller S Z Gesamte Inn Med; 1989 Aug; 44(16):469-76. PubMed ID: 2683430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]